ASX:MDC

Email Alerts for:
ASX:MDC

Medlab receives license to export cannabis

11 Sep 2018 - Medical Sciences Company, Medlab Clincial (ASX:MDC) has received a license to export Cannabis from the office of Drug Control (ODC) as it relates to 2 pioneering cann…

Medlab receives ‘largest’ cannabis oil shipment for trial

27 Jul 2018 - A leading cannabis company, Aphria, has sent its largest ever cannabis oil export shipment to Medlab Australia (ASX:MDC).

Heavyweights drag market: Aus shares lower at noon

15 May 2018 - The Australian share market opened lower following mixed leads from Wall Street. Index heavyweights NAB (ASX:NAB) and Telstra (ASX:TLS) were a drag on the market down…

Medlab Clinical receives approval to sell cannabis product in QLD and ACT

01 Feb 2018 - Biotechnology company Medlab Clinical (ASX:MDC) announces it is permitted to sell or supply cannabis in Queensland and the ACT, following licence approvals from the t…

Stocks sink in a sea of red: Aus shares close 0.64% lower

10 Jan 2018 - Stocks sink in a sea of red: Aus shares close 0.64% lower. Experience Co Limited (ASX:EXP) enters into a trading halt pending an announcement by the company about an …

Medlab Clinical receives licence to sell cannabis product

10 Jan 2018 - Pathology practice Medlab Clinical (ASX:MDC) announces it has received a licence from the Victorian government which allows the company to sell and supply cannabis.

Medlab Australian patent granted

18 Sep 2017 - Medlab Clinical Limited (ASX:MDC) has been granted a 20 year Australian patent for its anti-depression product NRGBiotic.

Medlab granted approval for two cannabis trials

19 Jun 2017 - Medlab Clinical Limited (ASX:MDC) has been granted approval for two different cannabis based human trials.

Medlab granted approval for further depression trial

27 Mar 2017 - Medlab Clinical Limited (ASX:MDC) has been granted ethics approval for Phase 2a of its anti depression study.

Medlab signs agreement for cholesterol comparison study

06 Mar 2017 - Medlab Clinical Limited (ASX:MDC) announced it has signed an agreement to start a study which compares how ‘NanoStat’ compares to taking statin tablets to lower chole…